#USA #healthcare #Las Vegas #BofA Securities #Viatris

Viatris to Present at the BofA Securities 2025 Healthcare Conference

Viatris Inc., a prominent player in the global healthcare sector, is set to present at the upcoming BofA Securities 2025 Healthcare Conference in Las Vegas, Nevada. Scheduled for May 13, 2025, at 5 p.m. PT / 8 p.m. ET, this event serves as a platform for Viatris to share significant developments and future strategies that echo its mission of empowering global health.

As a company focused on bridging the gap between generic and branded medicines, Viatris aims to address healthcare needs on a holistic level. Its extensive product portfolio ensures that high-quality medicines reach approximately 1 billion patients annually, providing critical access from infancy to advanced age, and treating both acute and chronic health issues. The impending presentation at the conference will highlight Viatris's multifaceted approach to healthcare solutions and its relentless pursuit of expanding access to medicines.

A live webcast of the presentation will be available for those unable to attend in person, allowing stakeholders, investors, and industry experts to engage with the new information shared during the event. After the live event, an archived version of the presentation will also be accessible, providing ongoing insights into Viatris's operations and initiatives.

About Viatris

Viatris was established with the goal of creating a broad-reaching global healthcare enterprise. The company’s unique business model integrates both generic and brand medications, which allows it to serve a diverse patient base effectively. By combining its vast supply chain, scientific expertise, and an expansive portfolio of medicines, Viatris is well-positioned to tackle some of the world's most pressing healthcare challenges.

Headquartered in Pittsburgh, with operational centers in cities like Shanghai and Hyderabad, Viatris is strategic in its outreach, ensuring accessibility to quality healthcare worldwide. The company emphasizes not just the delivery of medicines, but also a commitment to sustainable health outcomes throughout various life stages. Whether addressing newborn care or late-life conditions, Viatris's approach is comprehensive and grounded in accessibility.

The upcoming presentation at the BofA Securities conference aligns perfectly with Viatris's goals as it seeks to engage with investors, healthcare professionals, and the media, fostering collaboration and transparency in its mission to enhance global health access. Further information about the company's initiatives can be found on their official website and through their investor relations channels.

In conclusion, the BofA Securities 2025 Healthcare Conference represents more than a mere presentation for Viatris; it symbolizes their advocacy for a healthier future and the ongoing commitment to bridging healthcare gaps worldwide.